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To examine the association of colonization by Staphylococ-
cus aureus and general population mortality, we followed 
10,598 adults for 8.5 years on average. Methicillin-suscep-
tible S. aureus colonization was not associated with death. 
Methicillin-resistant S. aureus carriage predicted death in a 
crude analysis but not after adjustment for socioeconomic 
status and co-morbidities.
Staphylococcus aureus is a common cause of mild to life-threatening infections. It is differentiated into methicil-
lin-susceptible S. aureus (MSSA) and methicillin-resistant 
S. aureus (MRSA); the emergence of isolates resistant to 
vancomycin has raised concern that the bacterium might 
become untreatable with current antimicrobial drugs (1). 
Whether S. aureus colonization influences general popu-
lation mortality remains unclear (2,3). Therefore, we ex-
amined the association in a US population representative 
sample followed for nearly a decade.
The Study
We used data from the 2001–2004 National Health 
and Nutrition Examination Survey (NHANES) and the 
NHANES 2001–2004 Mortality-Linked File. NHANES 
is a survey of the US noninstitutionalized civilian popu-
lation conducted by the Centers for Disease Control and 
Prevention’s National Center for Health Statistics. We 
selected 10,598 NHANES participants using a complex 
multistage sampling design and followed them through 
December 31, 2011, to track mortality. NHANES pro-
tocols were approved by the institutional review boards 
of NCHS and CDC, and all participants provided 
informed consent.
Nasal swabs collected from participants were tested 
for S. aureus and methicillin resistance during 2001–2004 
following the National Committee for Clinical Laboratory 
Standards disk-diffusion method. We additionally tested 
isolates resistant to oxacillin (MRSA) and intermediately 
resistant to oxacillin and every tenth isolate sensitive to 
oxacillin (MSSA) for staphylococcal cassette chromo-
some mec (SCCmec) typing, genes encoding enterotoxins, 
toxic shock syndrome toxin-1, and Panton-Valentine leu-
kocidin (PVL) toxin (details on the methods are available 
at http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/
l35_b_doc.pdf). We collected data on age, sex, race/eth-
nicity, family income, smoking, and medical conditions 
using questionnaires.
Univariate and multivariate Cox proportional hazards 
regressions were used to estimate the hazard ratio (HR) 
with corresponding 95% CIs for MSSA and MRSA associ-
ation with mortality. Analyses were performed in STATA 
version 11 (StataCorp LP, College Station, TX, USA), tak-
ing into account the survey design and sampling weights, to 
produce nationally representative estimates. We considered 
p values <0.05 as statistically significant.
A total of 27.3% of participants were colonized with 
MSSA and 1.3% with MRSA (Table 1). During an average 
of 8.5 years of follow-up, the total death rate per 1,000 per-
son-years was 10.3: 10.8 for noncolonized participants, 8.8 
for those colonized with MSSA, and 25.6%for those colo-
nized with MRSA. MRSA-colonized participants tended to 
be older and non-Hispanic white, have low poverty income 
ratio, smoke cigarettes, have co-morbidities, or have been 
hospitalized and/or have had dialysis in the previous 12 
months (Table 1). Approximately 58.6% of MRSA isolates 
were of SCCmec type II, suggestive of hospital-associated 
MRSA, and 41.4% had MRSA isolates of SCCmec type 
IV, indicative of community-associated MRSA.
In Cox regression, MSSA-colonized participants had 
a significantly lower risk for death than did noncolonized 
participants in univariate analysis (hazard ratio [HR] 
0.82, 95% CI 0.68–0.98) but not after adjustment for co-
variates. MRSA colonization was associated with higher 
risk for death than no S. aureus colonization in univari-
ate analysis (HR 2.40, 95% CI 1.56–3.69) and after ad-
justment for sociodemographic factors (HR 1.54, 95% 
CI 1.06–2.34); MRSA colonization also carried higher 
risk for death than MSSA colonization (HR 2.90, 95% 
CI 1.92–4.40). However, after additional adjustment for 
smoking, body mass index, and co-morbidities (asthma, 
diabetes, hypertension, cardiovascular diseases, stroke, 
liver disease, and cancer), these associations were no lon-
ger significant (Table 2).
Likewise, colonization with SCCmec type II MRSA 
more strongly predicted long-term mortality than did 
no S. aureus ((HR 3.38, 95% CI 2.00–5.72) or MSSA 
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colonization (HR 4.05, 95% CI 2.42–6.79) in univariate 
analyses but not after adjustment for sociodemograph-
ic characteristics. Colonization with SCCmec type IV 
MRSA was not associated with death in univariate or 
adjusted analysis, unlike no S. aureus or MSSA colo-
nization (Table 2). However, the small number of par-
ticipants with MRSA SCCmec types II (83) and IV (53) 
limited our analysis.
Conclusions
In this population-based study, we found that MSSA is 
not associated with long-term mortality. MRSA is asso-
ciated with risk for death in crude analysis but not after 
adjustment for socioeconomic factors, co-morbidities, 
or both.
Regarding MSSA, our results are consistent with 
studies conducted in inpatient and nursing home partici-
pants that also failed to find an association (4–7). Many of 
these studies were underpowered, calling for larger scale 
investigations. In line with the inverse association in our 
unadjusted analysis for MSSA and mortality, Wertheim 
et al. found that MSSA-colonized participants had lon-
ger survival than did noncolonized participants among 
patients with S. aureus bacteremia (3). They suggested 
that colonized patients might be more immunologically 
adapted to the endogenous S. aureus strains that caused 
the bacteremia or that exogenous strains in noncolonized 
patients were more virulent. In our case, we hypothesized 
that the negative association was imputable to some con-
founders, such as race/ethnicity, smoking, and co-mor-
bidities (hypertension, cardiovascular diseases, stroke), 
instead of an independent association. We found that 
persons with MSSA were more likely to be non-Hispan-
ic white and have asthma or diabetes than were persons 
without S. aureus nasal carriage, who were more likely be 
non-Hispanic black; have a lower poverty income ratio; 
be a smoker; and have hypertension, cardiovascular dis-
eases, stroke, liver disease, or cancer. Concerning MRSA, 
Chan et al. observed that MRSA colonization was associ-
ated with higher mortality than non-MRSA colonization 
in nursing home residents in China followed for 2 years 
(8). Previous research also found that methicillin resis-
tance in S. aureus bacteremia did not predict long-term 
mortality after adjustment for age, comorbidities, severity 
of acute illness, metastatic infections, and long-term facil-
ity resident status (1).
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Table 1. Characteristics of study participants by Staphylococcus aureus colonization status, National Health and Nutrition Examination 
Survey, United States, 2001–2004* 
Characteristic No S. aureus MSSA MRSA p value† All participants, N = 10,598 
Prevalence 71.4 27.3 1.3  100 
Median age, y (IQR) 43 (31–56) 41 (30–54) 54 (34–67)  43 (31–55) 
Sex    <0.001  
 M 46.1 54.0 36.4  48.1 
 F 53.9 46.0 63.6  51.9 
Race/ethnicity    <0.001  
 Non-Hispanic white 70.3 74.4 80.8  71.5 
 Non-Hispanic black 12.1 8.4 11.7  11.1 
 Hispanic 12.4 12.8 4.5  12.4 
 Other 5.2 4.5 3.0  5.0 
Body mass index    .28  
 Normal or underweight 34.6 32.6 33.8  34.0 
 Overweight or obese 62.4 65.0 63.6  63.2 
 Missing 3.0 2.4 2.5  2.8 
Poverty income ratio    <0.001  
 <1.85 30.4 29.4 42.7  30.3 
 >1.85 64.1 64.3 47.7  63.9 
 Missing 5.5 6.3 0.6  5.8 
Smoking 49.2 44.6 63.8 <0.001 48.1 
Co-morbidities      
 Asthma 11.9 12.9 20.5 .07 12.3 
 Diabetes 8.1 9.4 13.5 .13 8.6 
 Hypertension 33.0 30.3 39.5 .05 32.4 
 Cardiovascular diseases‡ 6.1 4.6 12.5 .01 5.7 
 Stroke 2.7 1.9 4.9 .03 2.5 
 Liver disease 3.4 3.1 2.6 .76 3.3 
 Cancer 8.9 7.3 16.7 .02 8.5 
 Hospitalization and/or dialysis in past 12 mo 10.5 10.6 19.8 <0.001 10.6 
Mean survival, y (SE) 8.47 (0.11) 8.67 (0.10) 7.5 (0.28) <0.001 8.52 (0.10) 
Death during follow up 9.1 7.7 19.3 <0.001 8.9 
*All values are percentages except as indicated. IQR, interquartile range; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin resistant S. aureus.  
†p values for comparison of non–S. aureus colonization vs. MRSA colonization vs. MSSA colonization; p values calculated using 2 test for categorical 
variables and analysis of variance for continuous variables. 
‡Coronary heart disease, congestive heart failure, and myocardial infarction. 
 
DISPATCHES
Delayed treatment initiation, virulence factors such 
as PVL, or both have been hypothesized to be responsible 
for excess mortality in MRSA infections and bacteremia. 
Subsequent research found that PVL was associated with 
decreased time from colonization to bacteremia but not to 
mortality (9). Again in confirmation of our results, Han 
et al. studied the effect of SCCmec type on the 30-day in-
hospital mortality in 184 patients with MRSA and found 
SCCmec II significant in univariate analysis, but not after 
co-variates adjustment (10). That study also concluded that 
SCCmec II was a marker for disease severity instead of a 
predictor of mortality. 
Our study had several limitations. The carriage of S. 
aureus could be transient in some cases and not always 
reflect the carriage pattern over time. Although the nares 
are the most common site for S. aureus carriage, extranasal 
sites can also harbor the organism (11). S. aureus carriage 
was tested in 2001–2004 and might not reflect the current 
epidemiology and MRSA strain types. Data on co-morbid-
ities, such as cardiovascular or liver diseases and cancer, 
were not available for participants 18–19 years of age and 
were coded as missing in the analyses. We did not com-
pare death for the genes encoding enterotoxins because of 
their limited numbers. However, these NHANES data are 
the only national data available, and the major strengths of 
our study include the sample size representative of the US 
population with generalizable findings and higher power 
for statistical inferences.
Our findings are of public health and clinical impor-
tance because a lack of independent association between 
colonization by S. aureus and mortality implies that decolo-
nization might not prevent death. Some studies indicate that 
decolonization of patients at high risk for infections could 
reduce the number of subsequent S. aureus infections, but 
evidence remains limited that it prevents death (5).
Dr. Mendy is a physician completing a PhD in epidemiology at 
the University of Iowa. His research focuses on infectious causes 
of chronic diseases.
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Table 2. Cox proportional hazards regression for Staphylococcus aureus colonization and long-term mortality, United States* 
Exposure variable‡ 
No. 
deaths 
No. 
patients 
Unadjusted 
 
Model 1 
 
Model 2 
HR† (95% CI) p value HR† (95% CI)§ p value HR† (95% CI)¶ p value 
S. aureus colonization           
 No S. aureus 1,051 7,794 1 (referent)   1 (referent)   1 (referent)  
 MSSA 279 2,668 0.82 (0.68–0.98) 0.035  1.03 (0.85–1.24) 0.79  1.06 (0.88–1.27) 0.52 
 MRSA 41 136 2.40 (1.56–3.69) <0.001  1.54 (1.06–2.34) 0.026  1.38 (0.88–2.17) 0.15 
  MRSA SCCmec II 36 83 3.38 (2.00–5.72) <0.001  1.42 (0.88–2.26) 0.14  1.40 (0.87–2.24) 0.16 
  MRSA SCCmec IV 5 53 1.07 (0.37–3.12) 0.9  2.05 (0.60–7.03) 0.25  1.96 (0.55–6.92) 0.29 
In colonized participants           
 MSSA 279 2,668 1 (referent)   1 (referent)   1 (referent)  
 MRSA 41 136 2.90 (1.92–4.40) <0.001  1.48 (0.94–2.32) 0.09  1.27 (0.76–2.13) 0.35 
  MRSA SCCmec II 36 83 4.05 (2.42–6.79) <0.001  1.36 (0.84–2.21) 0.2  1.17 (0.66–2.08) 0.58 
  MRSA SCCmec IV 5 53 1.30 (0.44–3.84) 0.63  1.90 (0.54–6.64) 0.3  1.97 (0.58–6.70) 0.26 
*HR, hazard ratio; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus; SCCmec: staphylococcal cassette chromosome mec. 
†Generated by using Cox proportional hazards regression. 
‡Categorized into no S. aureus colonization (0), MSSA colonization (1) and MRSA colonization (2), to generate hazard ratios for MSSA colonization (1) 
and MRSA colonization (2) in reference to no S. aureus colonization (0). In the analysis by SCCmec types, exposure was categorized into: no S. aureus 
colonization (0), MSSA colonization (1), MRSA SCCmec II (2), and MRSA SCCmec IV (3) and hazard ratios for MRSA SCCmec II (2), and MRSA 
SCCmec IV were reported. In colonized participants, the analysis was repeated with MSSA colonization being the reference category. 
§Adjusted for age, sex, race/ethnicity, and Poverty Income Ratio. 
¶Adjusted for age, sex, race/ethnicity, poverty Income ratio, smoking, body mass index, and co-morbidities (asthma, diabetes, hypertension, 
cardiovascular diseases, stroke, liver disease, and cancer). 
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